临理面对面 | 北京大学肿瘤医院:淋巴瘤示范中心领航向,共探淋巴瘤诊疗新境
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/mmbiz_gif/oibBq71TGAe6NaYXHcrdGVzlUM9pxKJicDoDQ6bHyDbgDxGJvarFiaTzCQZBAlDL6wbhJOWIn9bJM3SS4H2JiaJ5Ow/640?wx_fmt=gif&tp=webp&wxfrom=5&wx_lazy=1" style="width: 50%; margin-bottom: 20px;"></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">“临理面对面”</strong>旨在深度挖掘、广泛分享淋巴瘤诊疗示范中心的宝贵经验,并以此<span style="color: black;">做为</span>全国其他中心推进淋巴瘤专科建设的蓝本,进一步<span style="color: black;">提高</span>淋巴瘤的诊疗水平。本期“临理面对面”特邀来自<strong style="color: blue;">北京大学肿瘤医院</strong>的临床与病理杰出专家——<strong style="color: blue;">朱军教授、张晨教授</strong>以及<strong style="color: blue;">时云飞教授</strong>,以临理共话的形式,深入探讨淋巴瘤<span style="color: black;">行业</span>的最新发展与实践,共探淋巴瘤诊疗新境!</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;"><span style="color: black;">精细</span>诊断引路,规范治疗护航</strong></span></p><span style="color: black;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">关闭</div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><strong style="color: blue;">观看<span style="color: black;">更加多</span></strong></div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><span style="color: black;">更加多</span></div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">退出全屏</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">视频加载失败,请刷新页面再试</p><a style="color: black;"><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;"> 刷新 </a>
</div><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;">
</div>
</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;"> <a style="color: black;"> 视频详情 </a> </div>
</div>
</span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">医脉通:请您结合经验,谈谈您中心在对CD30+淋巴瘤<span style="color: black;">病人</span>实行规范诊疗过程中遇到过<span style="color: black;">那些</span>诊断和治疗难点?<span style="color: black;">那些</span>方面<span style="color: black;">必须</span><span style="color: black;">尤其</span>关注?</strong></span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_png/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjnNXdhguqa6aFZQ0iaSf2FPlFv5eJlz7R4sYGXlFcMNgDQAfhZhqFH8g/640?wx_fmt=png&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">朱军 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;"><span style="color: black;"><span style="color: black;">针对</span>CD30+淋巴瘤,准确的病理诊断是极为<span style="color: black;">重要</span>的一步,<span style="color: black;">可否</span>有CD30阳性是临床<span style="color: black;">大夫</span>为<span style="color: black;">病人</span><span style="color: black;">选取</span><span style="color: black;">药品</span>、进行<span style="color: black;">精细</span>治疗的前提。</span></strong><span style="color: black;"><span style="color: black;">因此呢</span>,临床<span style="color: black;">大夫</span>与病理科<span style="color: black;">大夫</span>的合作与<span style="color: black;">协同</span>非常<span style="color: black;">要紧</span>,可为经典型霍奇金淋巴瘤(cHL)和外周T细胞淋巴瘤(PTCL)等CD30+淋巴瘤<span style="color: black;">病人</span><span style="color: black;">供给</span>准确的病理诊断,助力后续治疗<span style="color: black;">方法</span>的制订。</span></span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">针对CD30+淋巴瘤,靶向CD30的抗体偶联<span style="color: black;">药品</span>(ADC)维布妥昔单抗(BV)<span style="color: black;">已然</span>在国内上市并且纳入<span style="color: black;">医疗保险</span>目录,带来了新的治疗<span style="color: black;">选取</span>。值得<span style="color: black;">重视</span>的是,临床<span style="color: black;">大夫</span>为<span style="color: black;">病人</span>制订治疗<span style="color: black;">方法</span>之后,还<span style="color: black;">必须</span>监测毒副反应、做好安全性管理,从而让<span style="color: black;">病人</span>最大程度获益。</span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjUcx8To9ZW3k5AAA0RGxicJheGNicibqlmf2wTkuC7OCzENEO7PjlazF6A/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">张晨 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;">在我中心cHL的临床治愈率高达80%以上,但仍有10%-20%<span style="color: black;">显现</span>复发/难治,尤其是晚期的高危<span style="color: black;">病人</span>。<span style="color: black;">针对</span>侵袭性T细胞淋巴瘤,在<span style="color: black;">初期</span>化疗效果较好的<span style="color: black;">状况</span>下,可能<span style="color: black;">必须</span>进行自体造血干细胞移植(ASCT)以巩固疗效。总之,</span><strong style="color: blue;"><span style="color: black;">ASCT在CD30+淋巴瘤<span style="color: black;">病人</span>中起着<span style="color: black;">要紧</span>的<span style="color: black;">功效</span>。</span></strong></span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;">然而</span></span><span style="color: black;">,据统计数据<span style="color: black;">显示</span>,<span style="color: black;">日前</span>国内整体移植数量同欧美国家仍存在差距,</span><span style="color: black;"><span style="color: black;">且大部分为异基因移植,ASCT的占比较低。<span style="color: black;">按照</span>CSCO自体移植工作组的统计,</span><strong style="color: blue;"><span style="color: black;">我国ASCT率仅为2.4%</span></strong><span style="color: black;">,在经济欠发达地区更低。<span style="color: black;">思虑</span>到ASCT<span style="color: black;">关联</span>技术<span style="color: black;">已然</span>非常成熟,大<span style="color: black;">都数</span><span style="color: black;">病人</span>在<span style="color: black;">医疗保险</span>报销之后可<span style="color: black;">包袱</span>,<span style="color: black;">因此呢</span>呼吁国内医疗中心对ASCT给予<span style="color: black;">更加多</span><span style="color: black;">注意</span>。</span></span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;"><span style="color: black;">另外</span>,临床<span style="color: black;">大夫</span><span style="color: black;">亦</span>要<span style="color: black;">注意</span><span style="color: black;">药品</span>安全性管理,</span><strong style="color: blue;"><span style="color: black;"><span style="color: black;">针对</span>老年<span style="color: black;">病人</span>和合并症<span style="color: black;">病人</span><span style="color: black;">必须</span>关注治疗过程中的并发症;<span style="color: black;">因为</span><span style="color: black;">青春</span><span style="color: black;">病人</span>治疗效果较好,临床<span style="color: black;">大夫</span>更<span style="color: black;">必须</span>关注治疗的不良反应</span></strong><span style="color: black;">,<span style="color: black;">尤其</span>是<span style="color: black;">针对</span><span style="color: black;">哪些</span>有生育需求的<span style="color: black;">病人</span>,提前做好<span style="color: black;">关联</span>工作,从而让<span style="color: black;">病人</span>活得更长、更好。</span></span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjbuBWBtoG520icIeBUIsAF1uytr6iaowu9cQax1LEuB2d95WUboBeD80Q/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">时云飞 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">随着CD30从单纯的诊断标志物升级为辅助诊断+<span style="color: black;">指点</span>治疗的综合性标志物,病理科<span style="color: black;">大夫</span>的工作<span style="color: black;">亦</span>从定性诊断扩展至定性+定量的综合<span style="color: black;">评定</span>,<strong style="color: blue;">不仅要判断CD30的表达为阳性或阴性,还需精确检测其表达的百分比</strong>,以<span style="color: black;">指点</span><span style="color: black;">精细</span>治疗。当前,在标本处理、免疫组化检测<span style="color: black;">办法</span>、抗体<span style="color: black;">选取</span>及结果判读等方面,国内外病理<span style="color: black;">大夫</span>正致力于统一认知,为临床<span style="color: black;">大夫</span><span style="color: black;">供给</span>准确、一致的报告,<span style="color: black;">从而</span>促进临床决策的<span style="color: black;">精细</span>化。这是一个<span style="color: black;">连续</span><span style="color: black;">奋斗</span>、<span style="color: black;">持续</span><span style="color: black;">提高</span>的过程,是病理<span style="color: black;">大夫</span>肩负的<span style="color: black;">要紧</span>使命。</span></p><span style="color: black;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">关闭</div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><strong style="color: blue;">观看<span style="color: black;">更加多</span></strong></div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><span style="color: black;">更加多</span></div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">退出全屏</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">视频加载失败,请刷新页面再试</p><a style="color: black;"><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;"> 刷新 </a>
</div><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;">
</div>
</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;"> <a style="color: black;"> 视频详情 </a> </div>
</div>
</span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">医脉通:基于CD30在cHL、ALCL等多种淋巴瘤亚型中有不同程度的表达,CD30检测在病理诊断中<span style="color: black;">拥有</span><span style="color: black;">要紧</span>地位,<span style="color: black;">怎样</span>做好CD30的病理检测全流程标准化、规范化管理?CD30靶向<span style="color: black;">药品</span>BV进入<span style="color: black;">医疗保险</span>目录已超过1年,对现有治疗格局产生了<span style="color: black;">那些</span>影响?<span style="color: black;">怎样</span>规范用药使<span style="color: black;">病人</span>获益最大?</strong></span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjbuBWBtoG520icIeBUIsAF1uytr6iaowu9cQax1LEuB2d95WUboBeD80Q/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">时云飞 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">CD30检测<span style="color: black;">重点</span>依赖于石蜡标本的免疫组化<span style="color: black;">办法</span>,<span style="color: black;">触及</span>组织固定、脱水、透明、浸蜡及制片等多个环节。<strong style="color: blue;">其中标本的固定尤为<span style="color: black;">重要</span>,需<span style="color: black;">保证</span>组织离体后半小时内放入福尔马林,<span style="color: black;">倘若</span>淋巴组织有坚硬质密的背膜需切开,固<span style="color: black;">按时</span>间应<span style="color: black;">掌控</span>在6-24小时。</strong><span style="color: black;">另外</span>,免疫组化检测平台的<span style="color: black;">选取</span>和抗体质量<span style="color: black;">也</span>至关<span style="color: black;">要紧</span>,为<span style="color: black;">保证</span>检测准确性,需设立良好的阳性及阴性对照<span style="color: black;">做为</span>判读标准,<span style="color: black;">详细</span>可参照《淋巴瘤CD30免疫组织化学检测及结果判读规范》;不同中心在<span style="color: black;">运用</span>不同检测仪器时,<strong style="color: blue;">应以阳性对照达到最佳阳性状态为基准</strong>,<span style="color: black;">调节</span>抗体<span style="color: black;">运用</span>和检测试剂参数。如此<span style="color: black;">败兴</span>,做好CD30的病理检测全流程标准化、规范化管理,以便<span style="color: black;">得到</span>准确的病理诊断,来<span style="color: black;">指点</span>后续的治疗<span style="color: black;">药品</span><span style="color: black;">选取</span>。</span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_png/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjm8eiahoDGWqE8CIibFvlHjbUouJsDNxb5wc91mxjk4yiaBkKyp7ia3cWZA/640?wx_fmt=png&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">朱军 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">近年来,淋巴瘤治疗已然进入一个<span style="color: black;">精细</span>治疗时代,但相比于B细胞淋巴瘤,T细胞淋巴瘤的免疫靶向治疗<span style="color: black;">发展</span>相对滞后。<strong style="color: blue;">在众多血液学同行的<span style="color: black;">奋斗</span>下,靶向CD30 ADC BV在中国上市并纳入<span style="color: black;">医疗保险</span>,为HL和PTCL<span style="color: black;">供给</span>了新的治疗<span style="color: black;">选取</span>,并且<span style="color: black;">加强</span>了可及性。</strong>如今,BV从二线、三线治疗<span style="color: black;">逐步</span>进入一线治疗,这一新药<span style="color: black;">即时</span>且<span style="color: black;">精细</span>的应用,为初治和复发/难治性(R/R)CD30+淋巴瘤<span style="color: black;">病人</span>带来了全新的治疗机遇与<span style="color: black;">期盼</span>。</span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFj9v7EaDWFmBOBnJ7ZxHiau4bXaLzhFGXLZTtNTv8JewQuk7eRYUVSabA/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">张晨 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">近年来新药的<span style="color: black;">持续</span>涌现,给众多<span style="color: black;">病人</span>带来福音。<strong style="color: blue;">足量足疗程的规范化治疗,有助于充分发挥新药的治疗<span style="color: black;">潜能</span>,让CD30+淋巴瘤<span style="color: black;">病人</span>最大程度地获益。</strong>当CD30+淋巴瘤<span style="color: black;">病人</span>进入到复发难治的状态,例如R/R cHL的二线标准治疗为挽救治疗桥接ASCT,<span style="color: black;">因此呢</span><span style="color: black;">咱们</span>会<span style="color: black;">思虑</span>将BV加入挽救治疗来<span style="color: black;">提高</span><span style="color: black;">病人</span>的缓解率,让<span style="color: black;">她们</span>更快速实现缓解,从而尽快接受ASCT巩固。而高危R/R cHL<span style="color: black;">病人</span>移植后依然有<span style="color: black;">必定</span>的复发<span style="color: black;">发展</span>概率,<span style="color: black;">因此呢</span>可<span style="color: black;">思虑</span>含BV的维持治疗<span style="color: black;">方法</span>来进一步降低<span style="color: black;">病人</span>的复发<span style="color: black;">发展</span><span style="color: black;">危害</span>。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">北肿经验大揭秘,MDT模式大显身手</strong></span></p><span style="color: black;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">关闭</div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><strong style="color: blue;">观看<span style="color: black;">更加多</span></strong></div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><span style="color: black;">更加多</span></div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">退出全屏</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">视频加载失败,请刷新页面再试</p><a style="color: black;"><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;"> 刷新 </a>
</div><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;">
</div>
</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;"> <a style="color: black;"> 视频详情 </a> </div>
</div>
</span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">医脉通:CD30+淋巴瘤的规范诊疗离不开多学科的合作,北肿<span style="color: black;">做为</span>示范中心,请您介绍您中心的多学科诊疗模式,从病理到临床<span style="color: black;">怎样</span>推动多学科诊疗团队<span style="color: black;">有效</span>运作?示范中心的授牌离不开每一位<span style="color: black;">大夫</span>的<span style="color: black;">奋斗</span>,请您谈谈在推行规范诊疗过程中的经验和心得体会。</strong></span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_png/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjm8eiahoDGWqE8CIibFvlHjbUouJsDNxb5wc91mxjk4yiaBkKyp7ia3cWZA/640?wx_fmt=png&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">朱军 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">经过近三十年的发展,北京大学肿瘤医院将肿瘤内科逐步发展为淋巴瘤专科。<span style="color: black;">这里</span>过程中,<span style="color: black;">咱们</span>积极推动多学科协作(MDT)模式,促进病理科与影像科、外科等科室的紧密协作,<span style="color: black;">显著</span><span style="color: black;">提高</span>了淋巴瘤的诊断水平,使得北肿在全国范围内发挥了引领<span style="color: black;">功效</span>。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;"><span style="color: black;">不外</span>,</span><strong style="color: blue;"><span style="color: black;">中国淋巴瘤诊疗虽取得<span style="color: black;">明显</span>进步,但与发达国家相比仍有不小差距。</span></strong><span style="color: black;">面对地域发展不<span style="color: black;">平衡</span>的挑战,为实现“健康中国2030”<span style="color: black;">目的</span>,</span><strong style="color: blue;"><span style="color: black;"><span style="color: black;">咱们</span>还<span style="color: black;">必须</span>坚定推进规范化诊疗,<span style="color: black;">保证</span>每位淋巴瘤<span style="color: black;">病人</span>都能<span style="color: black;">得到</span>全生命周期的健康管理。</span></strong><span style="color: black;">这就<span style="color: black;">需求</span><span style="color: black;">咱们</span>对每一类型淋巴瘤进行<span style="color: black;">精细</span>诊断、分期和治疗,并实施全程管理,以尽可能<span style="color: black;">加强</span>治愈率。为此,<span style="color: black;">咱们</span>需加强院内及院际合作,<span style="color: black;">乃至</span>拓展至全国范围的行业合作,并<span style="color: black;">经过</span>遵循规范化诊疗路径、加强多学科合作与专科化发展,<span style="color: black;">持续</span>壮大淋巴瘤专业队伍,<span style="color: black;">最后</span>为淋巴瘤<span style="color: black;">病人</span>带来更好的治疗。</span></span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFj9v7EaDWFmBOBnJ7ZxHiau4bXaLzhFGXLZTtNTv8JewQuk7eRYUVSabA/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">张晨 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;"><span style="color: black;">北肿的MDT模式贯穿了淋巴瘤诊疗全程</span></strong><span style="color: black;">:活检时,临床<span style="color: black;">大夫</span>需判断<span style="color: black;">是由于</span>外科<span style="color: black;">大夫</span>切除还是影像科<span style="color: black;">大夫</span>在<span style="color: black;">彩超</span>引导下进行穿刺,并依赖于影像科和核医学科的<span style="color: black;">意见</span>来<span style="color: black;">选取</span>最佳活检部位;活检完成后,临床<span style="color: black;">大夫</span>与病理科<span style="color: black;">大夫</span>进行沟通,尽可能<span style="color: black;">保准</span>诊断的准确性;在<span style="color: black;">选取</span>治疗<span style="color: black;">方法</span>时,<span style="color: black;">咱们</span><span style="color: black;">亦</span>会和放疗科<span style="color: black;">大夫</span>探讨治疗方案的制订和放疗的介入<span style="color: black;">机会</span>。在<span style="color: black;">全部</span>治疗过程中,针对<span style="color: black;">病人</span>可能<span style="color: black;">显现</span>的不良反应和并发症,<span style="color: black;">咱们</span>还会与<span style="color: black;">呼气</span>科、感染科、心内科等相应科室的老师<span style="color: black;">一起</span>商议处理。</span></span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><span style="color: black;"><span style="color: black;">咱们</span>北肿<span style="color: black;">创立</span>了一个非常好的MDT平台,除了<span style="color: black;">能够</span>在平台上组织线下的疑难病例讨论,该平台还<span style="color: black;">包括</span>线上学习栏目,例如“北肿说系列”,会邀请不同科室老师进行授课,来加强多学科的联系。<span style="color: black;">另外</span>,<span style="color: black;">咱们</span>还会<span style="color: black;">定时</span>与兄弟单位进行MDT病例展示,实现院际的合作。</span><strong style="color: blue;"><span style="color: black;">这种MDT模式不仅<span style="color: black;">提高</span>了诊疗水平,<span style="color: black;">亦</span><span style="color: black;">保证</span>了<span style="color: black;">病人</span>得到更有效、个性化的治疗</span></strong><span style="color: black;">,<span style="color: black;">咱们</span>将继续深化这种模式,为<span style="color: black;">病人</span>带来更好的治疗效果。</span></span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjbNLtsFHst4MVuXH6d70ZMWZjlkBXMxd27DiaplASRrJxIz4kVhVoNGg/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">时云飞 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">MDT模式的开展有助于<span style="color: black;">连续</span>优化淋巴瘤的诊疗,<span style="color: black;">亦</span>有助于<span style="color: black;">咱们</span><span style="color: black;">大夫</span><span style="color: black;">持续</span>学习与成长。在开展MDT过程中,病理科虽然与其他医技科室所用诊断<span style="color: black;">办法</span>不同,但都是“盲人摸象”。虽然病理活检被誉为金标准,但临床<span style="color: black;">大夫</span><span style="color: black;">把握</span>的信息以及对<span style="color: black;">疾患</span>的整体把控<span style="color: black;">亦</span>非常<span style="color: black;">重要</span>,<span style="color: black;">因此呢</span>不同科室之间的密切沟通至关<span style="color: black;">要紧</span>。在<span style="color: black;">平常</span>工作中,<span style="color: black;">咱们</span>会<span style="color: black;">经过</span>开展正式的学术会议、<span style="color: black;">微X</span>交流、<span style="color: black;">tel</span>等<span style="color: black;">各样</span>方式进行<span style="color: black;">有效</span>沟通,来为<span style="color: black;">病人</span>制订更好的治疗<span style="color: black;">方法</span>。</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">与时俱进,共展新程</strong></span></p><span style="color: black;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">关闭</div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><strong style="color: blue;">观看<span style="color: black;">更加多</span></strong></div>
<div style="color: black; text-align: left; margin-bottom: 10px;"><span style="color: black;">更加多</span></div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">退出全屏</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">视频加载失败,请刷新页面再试</p><a style="color: black;"><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;"> 刷新 </a>
</div><img src="data:image/png;base64,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" style="width: 50%; margin-bottom: 20px;">
</div>
</div>
</div>
</div>
</div>
</div>
<div style="color: black; text-align: left; margin-bottom: 10px;">
<div style="color: black; text-align: left; margin-bottom: 10px;"> <a style="color: black;"> 视频详情 </a> </div>
</div>
</span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">医脉通:关于MDT诊治淋巴瘤的<span style="color: black;">将来</span>趋势,以及<span style="color: black;">将来</span>在CD30+淋巴瘤<span style="color: black;">行业</span>的<span style="color: black;">有些</span>可能的创新和改进方向,请您分享<span style="color: black;">有些</span>见解。</strong></span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFj9v7EaDWFmBOBnJ7ZxHiau4bXaLzhFGXLZTtNTv8JewQuk7eRYUVSabA/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">张晨 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">新药和新疗法的<span style="color: black;">研发</span><span style="color: black;">没</span>疑将为<span style="color: black;">病人</span>带来福祉,<span style="color: black;">因此呢</span><span style="color: black;">咱们</span>科室<span style="color: black;">长时间</span>致力于开展新药<span style="color: black;">关联</span>临床<span style="color: black;">科研</span>,旨在改善淋巴瘤<span style="color: black;">病人</span>的治疗效果,<span style="color: black;">加强</span><span style="color: black;">她们</span>的<span style="color: black;">存活</span>质量。<span style="color: black;">针对</span>人工智能(AI)等新时代下<span style="color: black;">显现</span>的新技术,我认为<strong style="color: blue;">虽然AI在个体化治疗模式中的<span style="color: black;">详细</span>角色尚不<span style="color: black;">知道</span>,但在诊断及其他过程中,AI或许能发挥<span style="color: black;">要紧</span><span style="color: black;">功效</span>。</strong></span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjbNLtsFHst4MVuXH6d70ZMWZjlkBXMxd27DiaplASRrJxIz4kVhVoNGg/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">时云飞 教授</strong></span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">从病理科<span style="color: black;">大夫</span>的<span style="color: black;">方向</span>看,CD30与PD-1均为蛋白标志物,<span style="color: black;">将来</span>CD30检测有可能参考PD-1的检测<span style="color: black;">办法</span>,引入能在同一张切片上检测多个靶点的多色荧光免疫组化或其他技术。<strong style="color: blue;"><span style="color: black;">将来</span>新技术AI的加入有望<span style="color: black;">加强</span>CD30定量判读的准确性和一致性。</strong></span></p><img src="https://mmbiz.qpic.cn/sz_mmbiz_png/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjm8eiahoDGWqE8CIibFvlHjbUouJsDNxb5wc91mxjk4yiaBkKyp7ia3cWZA/640?wx_fmt=png&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"><span style="color: black;"><strong style="color: blue;">朱军 教授</strong></span><span style="color: black;">正如两位教授<span style="color: black;">说到</span>的新技术与新疗法,<span style="color: black;">咱们</span>能看到时代的飞速发展正推动着淋巴瘤诊疗<span style="color: black;">持续</span>进步,从互联网的崛起到大数据的广泛应用,再到如今AI的深度融合,这些新兴技术为<span style="color: black;">咱们</span><span style="color: black;">供给</span>了全新的诊断与治疗手段。<strong style="color: blue;"><span style="color: black;">咱们</span>应保持<span style="color: black;">连续</span>学习的态度,在实践中<span style="color: black;">持续</span><span style="color: black;">累积</span>经验,向<span style="color: black;">病人</span>学习,向多学科合作的伙伴学习,与国内外同行交流互鉴。</strong><span style="color: black;">仅有</span>怀揣着一颗永不满足的学习之心,<span style="color: black;">咱们</span><span style="color: black;">才可</span>为淋巴瘤<span style="color: black;">病人</span><span style="color: black;">供给</span>更为<span style="color: black;">优秀</span>的服务。只要<span style="color: black;">咱们</span>坚守初心,坚定决心,就<span style="color: black;">必定</span>能够<span style="color: black;">持续</span><span style="color: black;">提高</span><span style="color: black;">咱们</span>的医疗水平,更好地服务于广大<span style="color: black;">病人</span>。</span><img src="https://mmbiz.qpic.cn/sz_mmbiz_png/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjm8eiahoDGWqE8CIibFvlHjbUouJsDNxb5wc91mxjk4yiaBkKyp7ia3cWZA/640?wx_fmt=png&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">朱军 教授</strong></span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">北京大学肿瘤医院党委书记、大内科<span style="color: black;">专家</span>、</span><span style="color: black;">淋巴瘤科<span style="color: black;">专家</span>、博士生导师</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">中国临床肿瘤学会(CSCO)理事会常委理事</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">中国临床肿瘤学会淋巴瘤专家委员会<span style="color: black;">专家</span>委员</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">北京市希思科临床肿瘤<span style="color: black;">科研</span>基金会副理事长</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">北京抗癌协会副理事长</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">北京癌症<span style="color: black;">恢复</span>会会长</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">中华医学会中华肿瘤分会副<span style="color: black;">专家</span>委员</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">国家卫健委能力建设和继续教育肿瘤学专家委员会 委员 血液肿瘤组组长</span></p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">《白血病·淋巴瘤》杂志副总编辑</p>
<img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFj9v7EaDWFmBOBnJ7ZxHiau4bXaLzhFGXLZTtNTv8JewQuk7eRYUVSabA/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">张晨 教授</strong></span></p><span style="color: black;">副<span style="color: black;">专家</span>医师,医学博士,毕业于北京大学医学部,现就职于北京大学肿瘤医院淋巴肿瘤内科。</span><span style="color: black;"><span style="color: black;"><span style="color: black;">重点</span><span style="color: black;">科研</span>方向:</span><span style="color: black;">淋巴瘤的诊治;干细胞移植;淋巴瘤临床<span style="color: black;">基本</span>转化。</span></span><span style="color: black;">担任:中国人体健康科技促进会淋巴瘤专委会常务委员,中国抗癌协会肿瘤靶向治疗专业委员会青年委员,中国医药教育协会科普健康教育中心专家顾问,北京大学青年岗位能手。</span><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe67XcpAydSfSt3jibJRKkGFjbNLtsFHst4MVuXH6d70ZMWZjlkBXMxd27DiaplASRrJxIz4kVhVoNGg/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;"><strong style="color: blue;">时云飞 教授</strong></span></p><span style="color: black;">医学博士</span><span style="color: black;">北京大学肿瘤医院病理科副<span style="color: black;">专家</span>医师</span><span style="color: black;">毕业于北京大学医学部病理系</span><span style="color: black;">从事病理工作10余年、侧重淋巴瘤病理诊断及<span style="color: black;">研究</span></span><span style="color: black;">美国City of Hope国家癌症中心<span style="color: black;">拜访</span>学者</span><span style="color: black;">CSCO抗白血病淋巴瘤联盟青年委员会委员</span><span style="color: black;">中国抗癌协会病理专业委员会淋巴瘤学组委员</span><span style="color: black;">中国人体健康科技促进会淋巴瘤专业委员会委员</span><span style="color: black;">中国医药教育学会淋巴瘤分会委员</span><span style="color: black;">北京肿瘤病理<span style="color: black;">精细</span>诊断<span style="color: black;">科研</span>会淋巴造血分会副秘书长</span><span style="color: black;">北京医学会病理学分会淋巴瘤学组委员</span><span style="color: black;">北京抗癌协会淋巴血液肿瘤专业委员会委员</span><span style="color: black;">《中华病理学杂志》通讯编委</span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">编辑:</span><span style="color: black;">Chole</span></p><span style="color: black;">审校:Chole</span><span style="color: black;">排版:Red</span><span style="color: black;">执行:Moly</span><span style="color: black;">本平台旨在为医疗卫生专业人士传递<span style="color: black;">更加多</span>医学信息。本平台<span style="color: black;">颁布</span>的内容,<span style="color: black;">不可</span>以任何方式取代专业的医疗<span style="color: black;">指点</span>,<span style="color: black;">亦</span><span style="color: black;">不该</span>被视为诊疗<span style="color: black;">意见</span>。如该等信息被用于<span style="color: black;">认识</span>医学信息以外的目的,本平台不承担<span style="color: black;">关联</span>责任。本平台对<span style="color: black;">颁布</span>的内容,并不<span style="color: black;">表率</span>同意其描述和观点。若<span style="color: black;">触及</span>版权问题,烦请权利人与<span style="color: black;">咱们</span>联系,<span style="color: black;">咱们</span>将尽快处理。</span>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><img src="https://mmbiz.qpic.cn/sz_mmbiz_jpg/oibBq71TGAe6icLjopLRXKUVJfHxmjR9Tic12cuibdDF8iaFz5HhMZUsPeOJDqQ8PnDjooCX3Rb5GY5ReBtOqZ7EFDQ/640?wx_fmt=jpeg&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1" style="width: 50%; margin-bottom: 20px;"></p><img src="https://mmbiz.qpic.cn/mmbiz_gif/YUyZ7AOL3on2ou2cLR5sGyIDj0TtdTfLPmfNm6iaYF4C3pViakMMfqnSdk5QdS52ErsTvOeygI8Qx1n64YZvvZSQ/640?wx_fmt=gif&tp=webp&wxfrom=5&wx_lazy=1" style="width: 50%; margin-bottom: 20px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">戳“阅读原文”,查看<span style="color: black;">更加多</span>内容</span></p>
i免费外链发布平台 http://www.fok120.com/ 你说得对,我们一起加油,未来可期。
页:
[1]